Search research articles
Contact Us
Filters
Showing results (31-40 of 71) with videos related to
Page
of 8
Sort By:
Cancers
|
May 28, 2022
Large-Scale Profiling of Extracellular Vesicles Identified miR-625-5p as a Novel Biomarker of Immunotherapy Response in Advanced Non-Small-Cell Lung Cancer Patients
Francesco Pantano, Francesca Zalfa, Michele Iuliani, et al.
Plos One
|
July 22, 2016
Treatment of Metastatic Colorectal Cancer Patients ≥75 Years Old in Clinical Practice: A Multicenter Analysis
Roberta Grande, Clara Natoli, Fabrizio Ciancola, et al.
Journal of Chemotherapy (Florence, Italy)
|
July 27, 2021
Clinical insights and prognostic factors from an advanced biliary tract cancer case series: a real-world analysis
Roberto Filippi, Francesco Leone, Lorenzo Fornaro, et al.
Cancers
|
July 12, 2025
TTF-1 Negativity Predicts Poor Outcomes in Advanced Non-Squamous NSCLC Also in the Immunotherapy Era: A Multicenter Cohort Study and Meta-Analysis
Leonardo Brunetti, Valentina Santo, Alessandro Galletti, et al.
Expert Opinion on Biological Therapy
|
April 5, 2017
Immunotherapy for colorectal cancer: where are we heading?
Debora Basile, Silvio Ken Garattini, Marta Bonotto, et al.
Critical Reviews in Oncology/Hematology
|
February 3, 2025
Navigating chemotherapy and immunotherapy in early-stage lung cancer. A critical review and statements from INTERACTION group
Chiara Catania, Claudia Proto, Chiara Bennati, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 1, 2026
Family history enrichment in Non-Small cell Lung Cancer: A cross-sectional - prospective study to inform referral for germline testing
Fabrizio Citarella, Francesco M Venanzi, Giulia Di Giovanni, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 15, 2022
Pralsetinib in RET fusion-positive non-small-cell lung cancer: A real-world data (RWD) analysis from the Italian expanded access program (EAP)
Antonio Passaro, Giuseppe Lo Russo, Francesco Passiglia, et al.
The Oncologist
|
September 2, 2017
Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy
Valentina Fanotto, Mario Uccello, Irene Pecora, et al.
Advances in Therapy
|
February 1, 2020
Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Outcomes with Nivolumab in Pretreated Non-Small Cell Lung Cancer (NSCLC): A Large Retrospective Multicenter Study
Alessandro Russo, Marco Russano, Tindara Franchina, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 71) with videos related to
Sort By:
Page
of 8
Cancers
|
May 28, 2022
Large-Scale Profiling of Extracellular Vesicles Identified miR-625-5p as a Novel Biomarker of Immunotherapy Response in Advanced Non-Small-Cell Lung Cancer Patients
Francesco Pantano, Francesca Zalfa, Michele Iuliani, et al.
Plos One
|
July 22, 2016
Treatment of Metastatic Colorectal Cancer Patients ≥75 Years Old in Clinical Practice: A Multicenter Analysis
Roberta Grande, Clara Natoli, Fabrizio Ciancola, et al.
Journal of Chemotherapy (Florence, Italy)
|
July 27, 2021
Clinical insights and prognostic factors from an advanced biliary tract cancer case series: a real-world analysis
Roberto Filippi, Francesco Leone, Lorenzo Fornaro, et al.
Cancers
|
July 12, 2025
TTF-1 Negativity Predicts Poor Outcomes in Advanced Non-Squamous NSCLC Also in the Immunotherapy Era: A Multicenter Cohort Study and Meta-Analysis
Leonardo Brunetti, Valentina Santo, Alessandro Galletti, et al.
Expert Opinion on Biological Therapy
|
April 5, 2017
Immunotherapy for colorectal cancer: where are we heading?
Debora Basile, Silvio Ken Garattini, Marta Bonotto, et al.
Critical Reviews in Oncology/Hematology
|
February 3, 2025
Navigating chemotherapy and immunotherapy in early-stage lung cancer. A critical review and statements from INTERACTION group
Chiara Catania, Claudia Proto, Chiara Bennati, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 1, 2026
Family history enrichment in Non-Small cell Lung Cancer: A cross-sectional - prospective study to inform referral for germline testing
Fabrizio Citarella, Francesco M Venanzi, Giulia Di Giovanni, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 15, 2022
Pralsetinib in RET fusion-positive non-small-cell lung cancer: A real-world data (RWD) analysis from the Italian expanded access program (EAP)
Antonio Passaro, Giuseppe Lo Russo, Francesco Passiglia, et al.
The Oncologist
|
September 2, 2017
Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy
Valentina Fanotto, Mario Uccello, Irene Pecora, et al.
Advances in Therapy
|
February 1, 2020
Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Outcomes with Nivolumab in Pretreated Non-Small Cell Lung Cancer (NSCLC): A Large Retrospective Multicenter Study
Alessandro Russo, Marco Russano, Tindara Franchina, et al.
Page
of 8